pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

9,798 catalysts · 3,350 8k filing · 2,046 grant · 1,007 approval · 1,000 device adverse event · 732 device 510k · 584 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 66 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-01-21×clear all
type
  • 8k filing3,350
  • grant2,046
  • approval1,007
  • device adverse event1,000
  • device 510k732
  • earnings584
device pma
539
  • device recall255
  • recall204
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Feb 16, 2026

    50
    ›Feb 16, 2026grant180d agoVANDERBILT UNIVERSITY MEDICAL CENTER — Genetic variant Evidence using Novel tools to Elucidate Pathophysiology: Acce...

    HG grant. $1,193,092. PI: Jada Benn Torres

    full page →nih reporter ↗
    ›Feb 16, 2026grant180d agoBAYLOR COLLEGE OF MEDICINE — Osteoclast Dysfunction in Lysinuric Protein Intolerance (LPI)Baylor College of Medicine

    HD grant. $50,526. PI: Cher Sha

    full page →nih reporter ↗
    ›Feb 16, 2026grant180d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Exploring Cholinergic Changes and their Associations with Sleep Alterations i...

    NS grant. $128,358. PI: Giulia Carli

    full page →nih reporter ↗
    ›Feb 16, 2026grant180d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — The NYU-Sage NAMs Data Hub and Coordinating Center: Harmonizing, Analyzing, a...New York University

    ES grant. $5,000,000. PI: Jineta Banerjee

    full page →nih reporter ↗
    ›Feb 16, 2026grant180d agoMEDICAL UNIVERSITY OF SOUTH CAROLINA — Epigenetic Regulation of Pre-and Post-Translational Signaling in Aortic Valve...

    HL grant. $247,600. PI: Cassandra Lucille Clift

    full page →nih reporter ↗
    ›Feb 16, 2026grant180d agoUNIVERSITY OF COLORADO DENVER — Biogenesis of hERG1a/1b ion channels in health and disease model cardiomyocytesUniversity of Colorado Denver

    HL grant. $249,000. PI: Lisandra Flores Aldama

    full page →nih reporter ↗
    ›Feb 16, 2026grant180d agoSTANFORD UNIVERSITY — Development of Self-Assembling Pyrrole-Imidazole Polyamides for the Treatment...Stanford University

    GM grant. $75,880. PI: Kevin Jaime Gonzalez

    full page →nih reporter ↗
    ›Feb 16, 2026grant180d agoUNIV OF MASSACHUSETTS MED SCH WORCESTER — Role of TNF signaling in CX3CR1hi macrophages in the regulation of TLS function

    DK grant. $75,520. PI: Katherine Lauren Kruckow

    full page →nih reporter ↗
    ›Feb 16, 2026grant180d agoUNIVERSITY OF MINNESOTA — Stromal regulation of pathological bone remodelingUniversity of Minnesota

    DK grant. $676,905. PI: Hai-Bin Ruan

    full page →nih reporter ↗
    ›Feb 16, 2026grant180d agoJOHNS HOPKINS UNIVERSITY — Social Context, Community Norms, and Adolescent Girls' Sexual Health and Well...Johns Hopkins University

    HD grant. $49,538. PI: Charlotte Greenbaum

    full page →nih reporter ↗
    ›Feb 16, 2026grant180d agoUT SOUTHWESTERN MEDICAL CENTER — Tachycardia-induced Metabolic Remodeling Drives Cardiac Dysfunction

    HL grant. $249,000. PI: Chengyi Tu

    full page →nih reporter ↗
    ›Feb 16, 2026grant180d agoPENNSYLVANIA STATE UNIVERSITY, THE — Evolutionary and drug resistance landscape of human tyrosine kinases

    HG grant. $806,828. PI: David Martin McCandlish

    full page →nih reporter ↗
    ›Feb 16, 2026grant180d agoOKLAHOMA STATE UNIVERSITY STILLWATER — Manipulating interferon levels toward a safe and effective live single-cycle ...

    AI grant. $403,320. PI: Antonius G Oomens

    full page →nih reporter ↗
    ›Feb 17, 2026approval179d agoBOSENTAN — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Feb 17, 2026approval179d agoGABAPENTIN — FDA approvalSciegen Pharmaceuticals Inc

    Sponsor: SCIEGEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 17, 2026approval179d agoIDELALISIB — FDA approvalIDELALISIB

    Sponsor: NATCO. Form: TABLET. Route: ORAL

    full page →IDELALISIB →fda approvals ↗
    ›Feb 17, 2026approval179d agoAMBRISENTAN — FDA approvalAMBRISENTAN

    Sponsor: WATSON LABS INC. Form: TABLET. Route: ORAL

    full page →AMBRISENTAN →fda approvals ↗
    ›Feb 17, 2026approval179d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Feb 17, 2026approval179d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Feb 17, 2026approval179d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Feb 17, 2026approval179d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Feb 17, 2026approval179d agoSODIUM PHENYLBUTYRATE — FDA approvalSODIUM PHENYLBUTYRATE

    Sponsor: NAVINTA LLC. Form: TABLET. Route: ORAL

    full page →SODIUM PHENYLBUTYRATE →fda approvals ↗
    ›Feb 17, 2026approval179d agoDEXMEDETOMIDINE HYDROCHLORIDE — FDA approvalDEXMEDETOMIDINE HYDROCHLORIDE

    Sponsor: TAGI. Form: INJECTABLE. Route: INJECTION

    full page →DEXMEDETOMIDINE HYDROCHLORIDE →fda approvals ↗
    ›Feb 17, 2026approval179d agoCOLCHICINE — FDA approvalCOLCHICINE

    Sponsor: MICRO LABS. Form: CAPSULE. Route: ORAL

    full page →COLCHICINE →fda approvals ↗
    ›Feb 17, 2026approval179d agoAMBRISENTAN — FDA approvalAMBRISENTAN

    Sponsor: SIGMAPHARM LABS LLC. Form: TABLET. Route: ORAL

    full page →AMBRISENTAN →fda approvals ↗
    ›Feb 17, 2026approval179d agoMEDICAL AIR, USP — FDA approval

    Sponsor: INDUSTRIAL WELDING SUPPLY CO OF HARVEY INC. Form: GAS. Route: INHALATION

    full page →fda approvals ↗
    ›Feb 17, 2026approval179d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval179d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval179d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval179d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval179d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval179d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval179d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval179d agoLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Feb 17, 2026approval179d agoNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (ETHINYL ESTRADIOL) — FDA approvalNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE →fda approvals ↗
    ›Feb 17, 2026approval179d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

    Sponsor: ALEMBIC. Form: GEL. Route: TOPICAL

    full page →METRONIDAZOLE →fda approvals ↗
    ›Feb 17, 2026approval179d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

    Sponsor: ALEMBIC. Form: GEL. Route: TOPICAL

    full page →METRONIDAZOLE →fda approvals ↗
    ›Feb 17, 2026approval179d agoRELGAABI (GABAPENTIN) — FDA approvalSciegen Pharmaceuticals Inc

    Sponsor: SCIEGEN PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 17, 2026approval179d agoANAGRELIDE HYDROCHLORIDE — FDA approvalTakeda Pharmaceuticals USA Inc

    Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 17, 2026approval179d agoAMLODIPINE BESYLATE — FDA approvalGraviti Pharmaceuticals Inc

    Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 17, 2026approval179d agoMEROPENEM — FDA approvalMEROPENEM

    Sponsor: QILU. Form: INJECTABLE. Route: INJECTION

    full page →MEROPENEM →fda approvals ↗
    ›Feb 17, 2026device 510k179d agoBiomendex OY — Adaptos®Fuse Bone Graft (510k cleared)

    Product code: MQV. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 17, 2026device 510k179d agoLiquet Medical, Inc. — Versus™ Catheter (VS110-9NB) (510k cleared)

    Product code: QEY. Advisory committee: Cardiovascular. Type: Special

    full page →fda device 510k ↗
    ›Feb 17, 2026device 510k179d agoJiangsu Yuyue Medical Equipment & Supply Co., Ltd. — YUWELL® Finger Pulse Oximeter (YX105, YX106, YX110, YX310) (510k cleared)

    Product code: DQA. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 17, 2026device 510k179d agoBiocomposites, Ltd. — Biosteon® Screw (510k cleared)

    Product code: MAI. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 17, 2026device 510k179d agoFujifilm Corporation — FUJIFILM Endoscope Model EG-S100XT and VS-1000 Display Unit (510k cleared)Fujifilm Holdings Corp

    Product code: FDS. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 17, 2026device 510k179d agoNingbo Shenyu Medical Equipment Co.,Ltd — Electric Wheelchair (W-A807, W-A807L) (510k cleared)

    Product code: ITI. Advisory committee: Physical Medicine. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 17, 2026device 510k179d agoCenterline Biomedical, Inc. — IOPS Visionary System (MC-3); IOPS Viewpoint Simple Curve Catheter, 75cm (C00751); IOPS Viewpoint Simple Curve Catheter, 125cm (C01251); IOPS Viewpoint Double Curve Catheter, 75cm (C00752); IOPS Viewpoint Double Curve Catheter, 125cm (C02152); IOPS Guidewire 2 (ATW-2); IOPS Fiducial Tracking Pad (T02111); IOPS Guidewire Handle (H01035) (510k cleared)

    Product code: DQK. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 17, 2026device pma179d agoMedtronic, Inc. — PulseSelect™ Pulsed Field Ablation (PFA) system (PMA supplement)Medtronic plc

    Supplement type: Normal 180 Day Track. Product code: QZI. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Feb 17, 2026device pma179d agoAlcon Research, LLC — UNIPURE C3F8 Ophthalmic Gas in the UNIFEYE Gas Delivery System, UNIPURE C3F8 Ophthalmic Gas in the UNIPEXY Gas Delivery (PMA supplement)

    Supplement type: 30-Day Notice. Product code: LPO. Advisory committee: OP. Decision: OK30

    full page →fda device pma ↗
    ← prev
    page 30 of 196
    next →
    $MDT91.62+1.15%